Monday, August 01, 2016 1:14:51 AM
Okay I won't lie I wrote this entire post without any mention of EVOK lol since it is EVOK board I found another article on google finance from englewood with the latest analysts opinions and recommendation:
http://www.engelwooddaily.com/shares-trending-upward-for-the-week-evoke-pharma-inc-nasdaqevok/533725/
EVOK has a predicted price of 10.02 with a rating of 2.90. The rating is broken down into 1-2 is a buy 4-5 is a sell 3 is a hold. So in other words EVOK is holding a buy recommendation, barely but it is a buy if it goes up one tenth of a point it will be downgraded into a hold. Regardless so far I have not seen one recommendation for sell by any source since Friday.
I truly appreciate your willingness to bring value to the future organization that I have visioned. As of right now I am primarily just building up a good name for myself. Because who am I compared to anyone else out there offering advice. I have a few people thus far that have seen value in my posts and saw that I keep it balanced. If I am invested in a stock I am posting, its the first not the last thing I mention so people know before all else I am invested which means yes i do have interest in it. However I will post just as much negative stuff as positive about that stock.
Such as EPRS, I was invested in that prior to the BK news. Despite my best interest I made a post about EPRS on a forum and blasted it on twitter multiple times that it had just filed for Chapter 7 and that if anyone even thinks about getting into it, they need to thoroughly do their own research and make sure they know what they are doing. I took a loss on it but I rather take a loss than take other peoples money to get out of a bad trade. I am a Buddhist and personally feel that good karma comes back.
If you don't mind I would like to copy your message and send it in a private message to a friend who I believe got caught in a pump at its peak. I want to highlight the patience part and I also feel that having that advice coming from someone who has had a very successful investing career might mean even more. I do not want to divulge his name as I doubt that he would want too many people knowing about his investment but I feel it will be beneficial to him.
Once I get things rolling with setting up an organized group of people that can be trusted I will let you know. As of right now it is still in development stages. I did create a board MEGA OTC MKT SCANS where I was going to begin getting people's attention and getting them in the concept of team work. Through team work trust will be built. That will be the hardest factor involved is getting the trust element in place. Trust is a hard thing to build but an easy thing to lose, even more so when you never even seen the other persons face and they are giving financial suggestions. However if I can get people to start working together the learning and hopefully earning will fall into place with the trust being built along the way.
<This is where I realized I totally forgot this was EVOK lol sorry>
Anyways as I continue to learn more I will keep it posted here. If anyone else following EVOK has any other sources of information from credible and respected sources, please share so that I can deliver it to other forums and blogs. Thank you so much. I hope you all have a great night and we will see what tomorrow brings.
My guess was a dip to $2.25 on EVOK but I am rethinking it will be $2.32. Just my theory based on listening and observing everyone else on other forums.
Michael Beaton
AKA
Investor10122
newinvestor105@gmail.com (will change soon)
Information gathering, sharing as well credible information sources is always welcome.
Recent EVOK News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 11:01:20 AM
- Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI • GlobeNewswire Inc. • 06/17/2024 12:30:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 12:00:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 10:09:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 09:02:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:56:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:53:59 PM
- Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference • GlobeNewswire Inc. • 05/16/2024 08:02:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:20:33 PM
- Evoke Pharma Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/14/2024 08:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:15:18 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/14/2024 08:05:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:00:15 PM
- Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications • GlobeNewswire Inc. • 04/17/2024 12:30:27 PM
- Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer • GlobeNewswire Inc. • 03/21/2024 08:15:59 PM
- Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/14/2024 08:05:28 PM
- Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024 • GlobeNewswire Inc. • 03/07/2024 09:10:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:15:06 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/20/2024 09:38:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 02:00:04 PM
- Evoke Pharma Announces Closing of $7.5 Million Public Offering • GlobeNewswire Inc. • 02/14/2024 12:30:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 10:15:35 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/09/2024 10:14:30 PM
- Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million • GlobeNewswire Inc. • 02/09/2024 12:30:48 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM